The FTSE 100 index slumped 99.42 points, 1.2%, at 8,025.77. The FTSE 250 closed down 295.73 points, 1.4%, at 20,427.80. The AIM All-Share fell 7.07 points, 1.0%, at 730.86.
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
pence - 'buy' Jefferies cuts GSK to 'hold' (buy) - price target 1,525 (2,000) pence Jefferies raises Ashtead price target to 6,800 (6,150) pence - 'buy' RBC raises National Grid price target to 1,150 ...
A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...
amid funding threats London, 11 November 2024 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced it is pledging ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...
comprises Munich-based corporate partner Ben Leyendecker and London-based debt finance partner Sam Sherwood, according to the ...
GlobalData on MSN6d
GSK CEO addresses declining trust in vaccines following Trump re-electionGSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...
On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...
The heat has been out of the life sciences market over the last 18 months, but new VC investments could fuel a comeback for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback